U.S. market Closed. Opens in 5 hours 7 minutes

EVLO | Evelo Biosciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
RevenueN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/A
Operating Expenses108.47M115.40M91.89M86.36M58.10M27.53MN/A
Selling, General & Admin29.91M31.75M22.27M23.23M18.22M7.57M3.89M
Research & Development78.55M83.64M69.62M63.13M39.88M19.96M9.13M
Other Operating Expenses61.00K486.00K-1.37M1.07M1.16MN/AN/A
Operating Income-108.47M-115.40M-91.89M-86.36M-58.10M-27.53M-13.03M
Other Expenses / Income-5.13M-6.35M-1.37M885.00K1.16M-516.00K-307.00K
Before Tax Income-113.60M-121.75M-93.26M-85.47M-56.95M-28.05M-13.33M
Income Tax Expenses930.00K428.00K409.00K190.00K-3.09MN/AN/A
Net Income-114.53M-122.18M-93.67M-85.66M-53.85M-28.05M-13.33M
Interest Expenses4.67M3.61M-2.11M1.05M1.56MN/AN/A
Basic Shares Outstanding4.36M2.65M1.97M1.60M1.09M18.81M3.75M
Diluted Shares Outstanding4.36M2.65M1.97M1.60M1.09M18.81M3.75M
EBITDA-108.41M-114.91M-91.89M-86.36M-58.10M-27.21M-12.53M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-108.92M-118.14M-95.37M-84.42M-55.38M-28.05M-13.33M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙